The challenge is that the tumor immune microenvironment is not a static backdrop but a constantly shifting ecosystem shaped by cancer cells, immune cells, stromal cells, cytokines, and physical ...

Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...

The Microfluidics Market has emerged as one of the most transformative segments within modern biotechnology, diagnostics, and pharmaceutical research. Microfluidics refers to the technology that ...

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood in the circulatory system and lodge themselves in other ...

A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to researchers at UNIST. Led by Professor Joo Hun Kang in the Department of Biomedical ...

A research team led by Associate Professor Yang Ke from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with the First Affiliated Hospital of Anhui ...

Active microvalves and passive microvalves in microfluidic chips. (A) Typical structure of active microvalve: sliding arm. PDMS structures contain a guiding channel and a fluidic channel and were ...

Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates purification and improves consistency. Since its adaptation to nanoscale materials, ...

Growing cells in three dimensions is critical for studying how tissues behave in the body, yet most laboratory platforms remain either too simple or too complex to use widely. Researchers now present ...